Alderson, M.R., Smith, C.A., Tough, T.W., Davis-Smith, T., Armitage, R.J., Falk, B., Roux, E., Baker, E., Sutherland, G.R., and Din, W.S. (1994). Molecular and biological characterization of human 4-1BB and its ligand. Eur. J. Immunol., 24(9), 2219-2227.

Appay, V, Dunbar, P.R., Callan, M., Klenerman, P., Gillespie, G.M., Papagno, L., Ogg, G.S., King, A., Lechner, F., Spina, C.A., et al. (2002). Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med., 8, 379-385.

Badovinac, V.P., Porter, B.B., and Harty, J.T. (2002). Programmed contraction of CD8(+) T cells after infection. Nat. Immunol., 3(7), 619-626.

Badovinac, V.P., Porter, B.B., and Harty, J.T. (2004). CD8+ T cell contraction is controlled by early inflammation. Nat. Immunol., 5(8), 809-817.

Bansal-Pakala, P., Jember, A.G., and Croft, M. (2001). Signaling through 0X40 (CD134) breaks peripheral T-cell tolerance. Nat. Med., 7(8), 907-912.

Bansal-Pakala, P., and Croft, M. (2002). Defective T cell priming associated with aging can be rescued by signaling through 4-1BB (CD137). J. Immunol., 169(9), 5005-5009.

Bertram, E.M., Lau, P., and Watts, T.H. (2002). Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection. J. Immunol., 168(8), 37773785.

Bertram, E.M., Dawicki, W., Sedgmen, B., Bramson, J.L., Lynch, D.H., and Watts, T.H. (2004). A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo. J. Immunol., 172(2), 981-988.

Blazar, B.R., Kwon, B.S., Panoskaltsis-Mortari, A., Kwak, K.B., Peschon, J.J., and Taylor, P.A. (2001). Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients. J. Immunol., 166(5), 31743183.

Bluestone, J.A., and Abbas, A.K. (2003). Natural versus adaptive regulatory T cells. Nat. Rev. Immunol., 3(3), 253-257.

Bukczynski, J., Wen, T., and Watts, T.H. (2003). Costimulation of human CD28- T cells by 4-1BB ligand. Eur. J. Immunol., 33(2), 446-454.

Byrne, J.A., Butler, J.L., and Cooper, M.D. (1988). Differential activation requirements for virgin and memory T cells. J. Immunol., 141, 3249-3257.

Callan, M.F., Tan, L., Annels, N., Ogg, G.S., Wilson, J.D., O'Callaghan, C.A., Steven, N., McMichael, A.J., and Rickinson, A.B. (1998). Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J. Exp. Med., 187, 1395-1402.

Callan, M.F., Fazou, C., Yang, H., Rostron, T., Poon, K., Hatton, C., and McMichael, A.J. (2000). CD8+ T-cell selection, function, and death in the primary immune response in vivo. J. Clin. Invest., 106(10), 1251-1261.

Cannons, J.L., Lau, P., Ghumman, B., DeBenedette, M.A., Yagita, H., et al. (2001). 4-1BBL induces cell division, sustains survival and enhances effector function ofCD4 and CD8 T cells with similar efficacy. J. Immunol., 167, 1313-1324.

Choi, B.K., Bae, J.S., Choi, E.M., Kang, W.J., Sakaguchi, S., Vinay, D.S., and Kwon, B.S. (2004). 4-1BB-dependent inhibition of immunosuppression by activated CD4+CD25+ T cells. J. Leukoc. Biol., 75(5), 785-791.

Chu, N.R., DeBenedette, M.A., Stiernholm, B.J., Barber, B.H., and Watts, T.H. (1997). Role of IL-12 and 4-1BB ligand in cytokine production by CD28+ and CD28- T cells. J. Immunol., 158(7), 3081-3089.

Cooper, D., Bansal-Pakala, P., and Croft, M. (2002). 4-1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicity. Eur. J. Immunol., 32(2), 521-529.

Croft, M., Bradley, L.M., and Swain, S.L. (1994). Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J. Immunol., 152, 2675-2685.

Croft, M. (2003). Co-stimulatory members of the TNFR family: Keys to effective T-cell immunity? Nat. Rev. Immunol., 3(8), 609-620.

Dawicki, W., and Watts, T.H. (2004). Expression and function of 4-1BB during CD4 versus CD8 T cell responses in vivo. Eur. J. Immunol., 34(3), 743-751.

Dawicki, W., Bertram, E.M., Sharpe, A.H., and Watts, T.H. (2004). 4-1BB and 0X40 act independently to facilitate robust CD8 and CD4 recall responses. J. Immunol., 173(10), 5944-5951.

DeBenedette, M.A., Chu, N.R., Pollok, K.E., Hurtado, J., Wade W.F., Kwon, B.S., and Watts, T.H. (1995). Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP. J. Exp. Med., 181(3), 985-992.

DeBenedette, M.A., Shahinian, A., Mak, T.W., and Watts, T.H. (1997). Costimulation of CD28- T lymphocytes by 4-1BB ligand. J. Immunol., 158(2), 551-559.

DeBenedette, M.A., Wen, T., Bachmann, M.F., Ohashi, P.S., Barber, B.H., Stocking, K.L., Peschon, J.J., and Watts, T.H. (1999). Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus. J. Immunol., 163(9), 4833-4841.

Diehl, L., den Boer, A.T., Schoenberger, S.P., van der Voort, E.I., Schumacher, T.N., Melief, C.J., Offringa, R., and Toes, R.E. (1999). CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy. Nat. Med., 5(7), 774779.

Diehl, L., vanMierlo, G.J., den Boer, A.T., vanderVoort, E., Fransen, M., vanBostelen, L., Krimpenfort, P., Melief, C.J., Mittler, R., Toes, R.E., and Offringa, R. (2002). In vivo triggering through 4-1BB

enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathway. J. Immunol., 168(8), 3755-3762.

Fallarino, F., Grohmann, U., Hwang, K.W., Orabona, C., Vacca, C., Bianchi, R., Belladonna, M.L., Fioretti, M.C., Alegre, M.L., and Puccetti, P. (2003). Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol., 4(12), 1206-1212.

Foell, J., Strahotin, S., O'Neil, S.P., McCausland, M.M., Suwyn, C., Haber, M., Chander, P.N., Bapat, A.S., Yan, X.J., Chiorazzi, N., Hoffmann, M.K., and Mittler, R.S. (2003). CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 mice. J. Clin. Invest, 111(10), 1505-1518.

Fontenot, J.D., Gavin, M.A., and Rudensky, A.Y. (2003). Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol., 4(4), 330-336.

Garin, L., Rigal, D., Souillet, G., Bernaud, J., Merieux, Y., and Philippe, N. (1996). Strong increase in the percentage of the CD8bright+ CD28- T-cells and delayed engraftment associated with cyclosporine-induced autologous GVHD. Eur. J. Haematol., 56(3), 119-123.

Gavin, M.A., Clarke, S.R., Negrou, E., Gallegos, A., and Rudensky, A. (2002). Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo. Nat. Immunol., 3(1), 33-41.

Goodwin, R.G., Din, W.S., Davis-Smith, T., Anderson, D.M., Gimpel, S.D., Sato, T.A., Maliszewski, C.R., Brannan, C.I., Copeland, N.G., Jenkins, N.A., et al. (1993). Molecular cloning of a ligand for the inducible T cell gene 4-1BB: A member of an emerging family of cytokines with homology to tumor necrosis factor. Eur. J. Immunol., 23(10), 2631-2641.

Gramaglia, I., Cooper, D., Miner, K.T., Kwon, B.S., and Croft, M. (2000). Co-stimulation of antigen-specific CD4 T cells by 4-1BB ligand. Eur. J. Immunol., 30, 392-402.

Greenwald, R.J., Boussiotis, VA., Lorsbach, R.B., Abbas, A.K., and Sharpe, A.H. (2001). CTLA-4 regulates induction of anergy in vivo. Immunity, 14(2), 145-155.

Hori, S., Nomura, T., and Sakaguchi, S. (2003). Control of regulatory T cell development by the transcription factor Foxp3. Science, 299(5609), 1057-1061.

Hurtado, J.C., Kim, S.H., Pollok, K.E., Lee, Z.H., and Kwon, B.S. (1995). Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28. J. Immunol., 155(7), 3360-3367.

Ito, F., Li, Q., Shreiner, A.B., Okuyama, R., Jure-Kunkel, M.N., Teitz-Tennenbaum, S., and Chang, A.E. (2004). Anti-CD137 monoclonal antibody administration augments the antitumor efficacy of dendritic cell-based vaccines. Cancer Res., 64(22), 8411-8419.

Khattri, R., Cox, T., Yasayko, S.A., and Ramsdell, F. (2003). An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol., 4(4), 337-342.

Kim, Y.J., Brutkiewicz, R.R., and Broxmeyer, H.E. (2002). Role of 4-1BB (CD137) in the functional activation of cord blood CD28(-)CD8(+) T cells. Blood, 100(9), 3253-3260.

Kim, J., Choi, S.P., La, S., Seo, J.S., Kim, K.K., Nam, S.H., andKwon, B. (2003). Constitutive expression of 4-1BB on T cells enhances CD4+ T cell responses. Exp. Mol. Med., 35(6), 509-517.

Laderach, D., Movassagh, M., Johnson, A., Mittler, R.S., and Galy, A. (2002). 4-1BB co-stimulation enhances human CD8(+) T cell priming by augmenting the proliferation and survival of effector CD8(+) T cells. Int. Immunol., 14(10), 1155-1167.

Lee, H.W., Park, S.J., Choi, B.K., Kim, H.H., Nam, K.O., and Kwon, B.S. (2002). 4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bc1-xl and Bfl-1. J. Immunol., 169, 4882-4888.

Lee, H.W., Nam, K.O., Seo, S.K., Kim, Y.H., Kang, H., and Kwon, B.S. (2003). 4-1BB cross-linking enhances the survival and cell cycle progression of CD4 T lymphocytes. Cell. Immunol., 223(2), 143-150.

Lee, S.W., Vella, A.T., Kwon, B.S., and Croft, M. (2005). Enhanced CD4 T cell responsiveness in the absence of 4-1BB. J. Immunol., 174(11), 6803-6808.

London, C.A., Lodge, M.P., and Abbas, A.K. (2000). Functional responses and costimulatordependence of memory CD4+ T cells. J. Immunol., 164, 265-272.

Maus, M.V, Thomas, A.K., Leonard, D.G., Allman, D., Addya, K., Schlienger, K., Riley, J.L., and June, C.H. (2002). Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands forthe T-cell receptor, CD28 and 4-1BB. Nat. Biotechnol., 20(2), 143-148.

McHugh, R.S., Whitters, M.J., Piccirillo, C.A., Young, D.A., Shevach, E.M., Collins, M., and Byrne. M.C. (2002). CD4+CD25+ immunoregulatory T cells: Gene expression analysis reveals a functional role forthe glucocorticoid-induced TNF receptor. Immunity, 16, 311-323.

Melero, I., Shuford, W.W., Newby, S.A., Aruffo, A., Ledbetter, J.A., Hellstrom, K.E., Mittler, R.S., and Chen, L. (1997). Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat. Med., 3(6), 682-685.

Morris, G.P., Chen, L., and Kong, Y.C. (2003). CD137 signaling interferes with activation and function of CD4+CD25+ regulatory T cells in induced tolerance to experimental autoimmune thyroiditis. Cell. Immunol., 226(1), 20-29.

Perez, VL., Van Parijs, L., Biuckians, A., Zheng, X.X., Strom, T.B., and Abbas, A.K. (1997). Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity., 6(4), 411417.

Pollok, K.E., Kim, Y.J., Zhou, Z., Hurtado, J., Kim, K.K., Pickard, R.T., and Kwon, B.S. (1993). Inducible T cell antigen 4-1BB. Analysis of expression and function. J. Immunol., 150(3), 771781.

Pollok, K.E., Kim, S.H., and Kwon, B.S. (1995). Regulation of 4-1BB expression by cell-cell interactions and the cytokines, interleukin-2 and interleukin-4. Eur. J. Immunol., 25(2), 488494.

Sakaguchi, S. (2004). Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol., 22, 531-562.

Salek-Ardakani, S., Song, J., Halteman, B.S., Jember, A.G., Akiba, H., Yagita, H., and Croft, M. (2003). 0X40 (CD134) controls memory T helper 2 cells that drive lung inflammation. J. Exp. Med., 198(2), 315-324.

Schwartz, R.H. (2003). T cell anergy. Annu. Rev. Immunol., 21, 305-334.

Seo, S.K., Choi, J.H., Kim, Y.H., Kang, W.J., Park, H.Y., Suh, J.H., Choi, B.K., Vinay, D.S., and Kwon, B.S. (2004). 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nat. Med., 10(10), 1088-1094.

Shuford, W.W., Klussman, K., Tritchler, D.D., Loo, D.T., Chalupny, J., Siadak, A.W., Brown, T.J., Emswiler, J., Raecho, H., Larsen, C.P., Pearson, T.C., Ledbetter, J.A., Aruffo, A., and Mittler, R.S. (1997). 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J. Exp. Med., 186(1), 47-55.

Starck, L., Scholz, C., Dorken, B., and Daniel, P.T. (2005). Costimulation by CD137/4-1BB inhibits T cell apoptosis and induces Bcl-xL and c-FLIP(short) via phosphatidylinositol 3-kinase and AKT/protein kinase B. Eur. J. Immunol., 35(4), 1257-1266.

Sun, Y., Lin, X., Chen, H.M., Wu, Q., Subudhi, S.K., Chen, L., and Fu, Y.X. (2002a). Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis. J. Immunol., 168(3), 1457-1465.

Sun, Y., Chen, H.M., Subudhi, S.K., Chen, J., Koka, R., Chen, L., and Fu, Y.X. (2002b). Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease. Nat. Med., 8(12), 1405-1413.

Takahashi, C., Mittler, R.S., and Vella, A.T. (1999). Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal. J. Immunol., 162(9), 5037-5040.

Tan, J.T., Whitmire, J.K., Ahmed, R., Pearson, T.C., and Larsen, C.P. (1999). 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J. Immunol. , 163(9), 4859-4868.

Tan, J.T., Whitmire, J.K., Murali-Krishna, K., Ahmed, R., Altman, J.D., Mittler, R.S., Sette, A., Pearson, T.C., and Larsen, C.P. (2000). 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination. J. Immunol., 164(5), 2320-2325.

Taraban, VY., Rowley, T.F., O'Brien, L., Chan, H.T., Haswell, L.E., Green, M.H., Tutt, A.L., Glennie, M.J., and Al-Shamkhani, A. (2002). Expression and costimulatory effects of the TNF receptor superfamily members CD134 (0X40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses. Eur. J. Immunol., 32, 3617-3627.

Wen, T., Bukczynski, J., and Watts, T.H. (2002). 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function. J. Immunol., 168(10), 4897-4906.

Werwitzke, S., Drescher, B., Schmidt, R.E., and Witte, T. (2000). CD8+ T cell populations in common variable immunodeficiency. Immunobiology., 202(2), 168-171. Wilcox, R.A., Tamada, K., Flies, D.B., Zhu, G., Chapoval, A.I., Blazar, B.R., Kast, W.M., and Chen, L. (2004). Ligation of CD137 receptor prevents and reverses established anergy of CD8+ cytolytic T lymphocytes in vivo. Blood., 103(1), 177-184. Zheng, G., Wang, B., and Chen, A. (2004). The 4-1BB costimulation augments the proliferation of CD4+CD25+ regulatory T cells. J. Immunol., 173(4), 2428-2434.

How To Bolster Your Immune System

How To Bolster Your Immune System

All Natural Immune Boosters Proven To Fight Infection, Disease And More. Discover A Natural, Safe Effective Way To Boost Your Immune System Using Ingredients From Your Kitchen Cupboard. The only common sense, no holds barred guide to hit the market today no gimmicks, no pills, just old fashioned common sense remedies to cure colds, influenza, viral infections and more.

Get My Free Audio Book

Post a comment